MAPT and early-onset autosomal dominant Alzheimer disease: CMA also degrades proteins associated with Alzheimer’s disease and frontotemporal dementia, such as MAPT (Tau) (Wang et al., 2009), TARDBP (Huang et al., 2014), and APP (Park et al., 2016).